Federal Acquisition Regulation; Submission for OMB Review; Debarment and Suspension, 38429 [E9-18466]

Download as PDF Federal Register / Vol. 74, No. 147 / Monday, August 3, 2009 / Notices the General Services Administration, Regulatory Secretariat (VPR), 1800 F Street, Room 4041, Washington, DC 20405, telephone (202) 501–4755. Please cite OMB Control No. 9000– 0026, Change Order Accounting, in all correspondence. Dated: July 28, 2009. Al Matera, Director, Office of Acquisition Policy. [FR Doc. E9–18465 Filed 7–31–09; 8:45 am] BILLING CODE 6820–EP–P Submit comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: FAR Desk Officer, OMB, Room 10102, NEOB, Washington, DC 20503, and a copy to the General Services Administration, Regulatory Secretariat (VPR), 1800 F Street, NW., Room 4041, Washington, DC 20405. FOR FURTHER INFORMATION CONTACT: Edward Loeb, Contract Policy Division, GSA (202) 501–0650 or via e-mail at Edward.Loeb@gsa.gov. The FAR requires contracts to be awarded to only those contractors determined to be responsible. Instances where a firm or its principals have been indicted, convicted, suspended, proposed for debarment, debarred, or had a contract terminated for default are critical factors to be considered by the contracting officer in making a responsible determination, 52.209–5, Certification Responsibility Matters, requires the disclosure of this information. SUMMARY: The Food and Drug Administration (FDA) is announcing the rates and payment procedures for fiscal year (FY) 2010 animal drug user fees. The Federal Food, Drug, and Cosmetic Act (the act), as amended by the Animal Drug User Fee Act of 2003 (ADUFA) and the Animal Drug User Fee Amendments of 2008 (ADUFA II), authorizes FDA to collect user fees for certain animal drug applications and supplements, on certain animal drug products, on certain establishments where such products are made, and on certain sponsors of such animal drug applications and/or investigational animal drug submissions. This notice establishes the fee rates for FY 2010. FOR FURTHER INFORMATION CONTACT: Visit FDA’s Web site at http://www.fda.gov/ ForIndustry/UserFees/AnimalDrug UserFeeActADUFA/default.htm or contact Lisa Kable, Center for Veterinary Medicine (HFV–10), Food and Drug Administration, 7529 Standish Pl., Rockville, MD 20855, 240–276–9718. For general questions, you may also email the Center for Veterinary Medicine (CVM) at: cvmadufa@fda.hhs.gov. SUPPLEMENTARY INFORMATION: B. Annual Reporting Burden I. Background Respondents: 89,995. Responses per Respondent: 12.223. Annual Responses: 1,100,000. Hours per Response: 0.0833. Total Burden Hours: 91,667. Obtaining Copies of Proposals: Requesters may obtain a copy of the information collection documents from the General Services Administration, Regulatory Secretariat (VPR), 1800 F Street, NW., Room 4041, Washington, DC 20405, telephone (202) 501–4755. Please cite OMB Control No. 9000–0094, Debarment and Suspension, in all correspondence. Section 740 of the act (21 U.S.C. 379j12) establishes four different kinds of user fees: (1) Fees for certain types of animal drug applications and supplements, (2) annual fees for certain animal drug products, (3) annual fees for certain establishments where such products are made, and (4) annual fees for certain sponsors of animal drug applications and/or investigational animal drug submissions (21 U.S.C. 379j-12(a)). When certain conditions are met, FDA will waive or reduce fees (21 U.S.C. 379j-12(d)). For FY 2009 through FY 2013, the act establishes aggregate yearly base revenue amounts for each of these fee categories. Base revenue amounts established for years after FY 2009 are subject to adjustment for workload. Fees for applications, establishments, products, and sponsors are to be established each year by FDA so that the revenue for each fee category will approximate the level established in the statute, after the level has been adjusted for workload. For FY 2010, the animal drug user fee rates are: $209,400 for an animal drug application; $145,200 for a supplemental animal drug application for which safety or effectiveness data is required and for an animal drug application subject to the criteria set forth in section 512(d)(4) of the act (21 U.S.C. 360b(d)(4)); $6,185 for an annual ADDRESSES: DEPARTMENT OF DEFENSE SUPPLEMENTARY INFORMATION: GENERAL SERVICES ADMINISTRATION A. Purpose NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [OMB Control No. 9000–0094] Federal Acquisition Regulation; Submission for OMB Review; Debarment and Suspension sroberts on DSKD5P82C1PROD with NOTICES AGENCIES: Department of Defense (DOD), General Services Administration (GSA), and National Aeronautics and Space Administration (NASA). ACTION: Notice of request for an extension to an existing OMB clearance. SUMMARY: Under the provisions of the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35), the Federal Acquisition Regulation (FAR) Secretariat will be submitting to the Office of Management and Budget (OMB) a request to review and approve an extension of a currently approved information collection requirement concerning [subject]. A request for public comments was published in the Federal Register at 74 FR 18716 on April 24, 2009. No comments were received. Public comments are particularly invited on: Whether this collection of information is necessary for the proper performance of functions of the FAR, and whether it will have practical utility; whether our estimate of the public burden of this collection of information is accurate, and based on valid assumptions and methodology; ways to enhance the quality, utility, and clarity of the information to be collected; and ways in which we can minimize the burden of the collection of information on those who are to respond, through the use of appropriate technological collection techniques or other forms of information technology. DATES: Submit comments on or before September 2, 2009. VerDate Nov<24>2008 16:05 Jul 31, 2009 Jkt 217001 38429 Dated: July 28, 2009. Al Matera, Director, Office of Acquisition Policy. [FR Doc. E9–18466 Filed 7–31–09; 8:45 am] BILLING CODE 6820–EP–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2009–N–0336] Animal Drug User Fee Rates and Payment Procedures for Fiscal Year 2010 AGENCY: Food and Drug Administration, HHS. ACTION: PO 00000 Notice. Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\03AUN1.SGM 03AUN1

Agencies

[Federal Register Volume 74, Number 147 (Monday, August 3, 2009)]
[Notices]
[Page 38429]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-18466]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

GENERAL SERVICES ADMINISTRATION

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[OMB Control No. 9000-0094]


Federal Acquisition Regulation; Submission for OMB Review; 
Debarment and Suspension

AGENCIES: Department of Defense (DOD), General Services Administration 
(GSA), and National Aeronautics and Space Administration (NASA).

ACTION: Notice of request for an extension to an existing OMB 
clearance.

-----------------------------------------------------------------------

SUMMARY: Under the provisions of the Paperwork Reduction Act of 1995 
(44 U.S.C. Chapter 35), the Federal Acquisition Regulation (FAR) 
Secretariat will be submitting to the Office of Management and Budget 
(OMB) a request to review and approve an extension of a currently 
approved information collection requirement concerning [subject]. A 
request for public comments was published in the Federal Register at 74 
FR 18716 on April 24, 2009. No comments were received.
    Public comments are particularly invited on: Whether this 
collection of information is necessary for the proper performance of 
functions of the FAR, and whether it will have practical utility; 
whether our estimate of the public burden of this collection of 
information is accurate, and based on valid assumptions and 
methodology; ways to enhance the quality, utility, and clarity of the 
information to be collected; and ways in which we can minimize the 
burden of the collection of information on those who are to respond, 
through the use of appropriate technological collection techniques or 
other forms of information technology.

DATES: Submit comments on or before September 2, 2009.

ADDRESSES: Submit comments regarding this burden estimate or any other 
aspect of this collection of information, including suggestions for 
reducing this burden to: FAR Desk Officer, OMB, Room 10102, NEOB, 
Washington, DC 20503, and a copy to the General Services 
Administration, Regulatory Secretariat (VPR), 1800 F Street, NW., Room 
4041, Washington, DC 20405.

FOR FURTHER INFORMATION CONTACT: Edward Loeb, Contract Policy Division, 
GSA (202) 501-0650 or via e-mail at Edward.Loeb@gsa.gov.

SUPPLEMENTARY INFORMATION: 

A. Purpose

    The FAR requires contracts to be awarded to only those contractors 
determined to be responsible. Instances where a firm or its principals 
have been indicted, convicted, suspended, proposed for debarment, 
debarred, or had a contract terminated for default are critical factors 
to be considered by the contracting officer in making a responsible 
determination, 52.209-5, Certification Responsibility Matters, requires 
the disclosure of this information.

B. Annual Reporting Burden

    Respondents: 89,995.
    Responses per Respondent: 12.223.
    Annual Responses: 1,100,000.
    Hours per Response: 0.0833.
    Total Burden Hours: 91,667.
    Obtaining Copies of Proposals: Requesters may obtain a copy of the 
information collection documents from the General Services 
Administration, Regulatory Secretariat (VPR), 1800 F Street, NW., Room 
4041, Washington, DC 20405, telephone (202) 501-4755. Please cite OMB 
Control No. 9000-0094, Debarment and Suspension, in all correspondence.

    Dated: July 28, 2009.
Al Matera,
Director, Office of Acquisition Policy.
[FR Doc. E9-18466 Filed 7-31-09; 8:45 am]
BILLING CODE 6820-EP-P